Related Experiment Video
Updated: Jan 20, 2026
06:03
Studying Visual Awareness and Motion-Induced Blindness
Published on: April 30, 2023
7.7K
Supporting Blind and Visually Impaired Persons in Managing Their Medication
Tanja Nedovic1, Nesljihan Umeri-Sali1, Kerstin Denecke1
1Bern University of Applied Sciences.
Studies in Health Technology and Informatics
|September 5, 2019
Summary
The MyPills mobile app aids medication adherence for visually impaired individuals by offering reminders and accessible drug information. Usability tests indicate the app is helpful and well-received by users.
Area of Science:
- Health Informatics
- Assistive Technology
- Patient Safety
Background:
- Medication non-adherence is a significant issue, exacerbated by challenges faced by blind and visually impaired individuals.
- Difficulty recognizing medication and reading package inserts compromises patient safety.
Purpose of the Study:
- To develop and evaluate a mobile application, MyPills, to support medication management for all users, with a focus on blind and visually impaired individuals.
- To enhance medication adherence and patient safety through accessible technology.
Main Methods:
- Development of the MyPills mobile application featuring medication intake and reordering reminders.
- Integration of screen reader compatibility and voice output for package inserts.
- Utilized eMediplan for medication data entry and Global Trade Item Number (GTIN) scanning for package identification.
- Conducted a usability test with six participants, including two who are blind.
Main Results:
- Usability testing demonstrated that participants, including blind users, found the MyPills app and its functionalities helpful.
- Users reported positive experiences and ease of use with the application's features.
Conclusions:
- The MyPills app presents a promising solution for improving medication management, particularly for blind and visually impaired patients.
- Further clinical studies are warranted to confirm the app's impact on medication compliance and intake behavior in patient populations.
Related Concept Videos
Blind Procedures
13.0K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.0K
Motion-induced Blindness
7.7K
Source: Laboratory of Jonathan Flombaum—Johns Hopkins University
One thing becomes very salient after basic exposure to the science of visual perception and sensation: what people see is a creation of the brain. As a result people may fail to see things, see things that are not there, or see things in a distorted way.
To distinguish between physical reality and what people perceive, scientists use the term awareness to refer to what people perceive. To study awareness, vision scientists...
One thing becomes very salient after basic exposure to the science of visual perception and sensation: what people see is a creation of the brain. As a result people may fail to see things, see things that are not there, or see things in a distorted way.
To distinguish between physical reality and what people perceive, scientists use the term awareness to refer to what people perceive. To study awareness, vision scientists...
7.7K
Inattentional Blindness
14.6K
Source: Laboratory of Jonathan Flombaum—Johns Hopkins University
We generally think that we see things pretty well if they are close by and right in front of us. But do we? We know that visual attention is a property of the human brain that controls what parts of the visual world we process, and how effectively. Limited attention means that we can't process everything at once, it turns out, even things that might be right in front of us.
In the 1960s, the renowned cognitive psychologist...
We generally think that we see things pretty well if they are close by and right in front of us. But do we? We know that visual attention is a property of the human brain that controls what parts of the visual world we process, and how effectively. Limited attention means that we can't process everything at once, it turns out, even things that might be right in front of us.
In the 1960s, the renowned cognitive psychologist...
14.6K
Heart Failure V: Medical Management
224
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
224
Endocarditis III: Medical Management
217
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
217
Myocarditis III: Medical Management
179
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
179